FOMAT adds first North Carolina endocrinology site

FOMAT Medical Research has added Creedmoor Centre Endocrinology in Raleigh as its first North Carolina site and first endocrinology-focused site. The move expands the network to more than 40 locations and gives local patients new access to clinical trials in diabetes and other endocrine conditions.

Why it matters: - The addition gives FOMAT a new foothold in North Carolina and deepens its push into endocrinology research. - Raleigh-area patients with diabetes, thyroid disorders, and other endocrine or metabolic conditions may gain access to more clinical trials through a practice they already know. - FOMAT is pairing geographic growth with specialty expertise, not just adding sites for scale.

What happened: - FOMAT announced that Creedmoor Centre Endocrinology has joined its national research site network. - Creedmoor Centre Endocrinology is FOMAT's first site in North Carolina. - Creedmoor Centre Endocrinology is also FOMAT's first site focused specifically on endocrinology. - The practice is based in Raleigh, North Carolina. - FOMAT now has more than 40 sites nationwide.

The details: - FOMAT said its network includes sites in California, Colorado, Michigan, New Mexico, Texas, Maryland, New Hampshire and Washington, D.C. - Creedmoor Centre Endocrinology was founded in 2008. - Dr. Julia Warren-Ulanch has led the practice since acquiring it in 2013. - Trisha Vanderploeg, DNP, joined the practice in fall 2024 and brings clinical research experience in pediatric endocrinology. - The practice's clinicians cover diabetes, thyroid disorders and other endocrine conditions. - FOMAT said the partnership provides centralized support for study startup, regulatory coordination and patient recruitment. - Creedmoor Centre Endocrinology will continue operating under its own clinical leadership. - The structure is meant to let the practice take on more trials without changing day-to-day care. - FOMAT said it looks for established community practices with existing patient trust and then adds the infrastructure needed to support research. - Patients can participate in studies through a physician they already know instead of being referred to a separate research site. - FOMAT's broader network includes Phase I through Phase IV clinical trials across multiple therapeutic areas. - FOMAT said it serves diverse and underserved patient populations through community-based research physician groups. - Creedmoor Centre Endocrinology says its team includes Dr. Warren-Ulanch, Dr. Georgina Polanco, Trisha Vanderploeg, four physician assistants and a dietician/Certified Diabetes Educator. - Creedmoor Centre Endocrinology says Dr. Polanco, who joined in 2020, is a native Spanish speaker and helps serve the practice's Latin American patient population. - The practice says it focuses on individualized care and serves patients from a wide range of backgrounds.

Between the lines: - The deal shows how FOMAT is using specialty practices to expand research access without building standalone sites from scratch. - Endocrinology is becoming a more important therapeutic area for FOMAT as chronic conditions like diabetes continue to drive clinical research demand. - For community practices, joining a site network can bring operational muscle that makes research feasible while preserving the existing care model.

What's next: - FOMAT said it expects endocrinology to remain a key growth area as it expands in 2026 and beyond. - The company also plans to keep adding sites in new states and communities across the country. - Creedmoor Centre Endocrinology patients may see more trial opportunities tied to endocrine and metabolic diseases.

The bottom line: - FOMAT is broadening its national research network by adding a specialty practice that strengthens both its geographic reach and its clinical depth in endocrinology.

More information: FOMAT Medical Research - FOMAT Medical Research on LinkedIn